Brazil suspends dengue vaccine following two deaths
Brazil has temporarily suspended its single-dose dengue vaccine following two suspicious deaths and several severe adverse reactions. Health officials stated that while a direct link has not been confirmed, the suspension is a precautionary measure.
Why it matters
The suspension of a major public health initiative impacts global efforts to combat dengue fever and raises questions about vaccine safety protocols.
Brazil s health minister said the effects had not been observed during tests on over 16,000 volunteers.
The report relies on official statements from the Brazilian health ministry and provides factual context regarding the vaccine trials.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in